发明名称 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES
摘要 The use of substd. catechol derivs. of formula (Ia), their physiologically hydrolysable esters and ethers, and pharmaceutically acceptable salts as therapeutic agents is new. Ra = NO2 or CN; Rb = H or halo; Rc = halo, NO2, CN, -(A)n-(Q)m-R1 or -(A)n-Q-R2; A = vinylene, opt. substd. by lower alkyl; n and m = zero or 1; R1 = COR3, aromatic carbocyclic gp. or, bonded via a C atom, an aromatic or partially unsatd. heterocycle; R2 = H or lower hydrocarbyl, opt. substd., satd. or partially unsatd.; R3 = OH; NH2; lower hydrocarbyl (opt. substd., satd. or partially unsatd.) bonded via O, imino or lower alkylimino; or an N-bound, satd. N-contg. heterocyclyl; Q = CO or C=N-(Z)p-R4; Z = O or imino; P = zero or 1; R4 = H or a satd. or partially unsatd. lower hydrocarbyl, opt. substd. and opt. bound via carbonyl gp. (Ia) are new cpds. when R = NO2, CN, -(A)n-(Q)m-R1 or -(A)n-Q-R21; R21 is as R2, excluding H; provisos: Ra = CN if Rc = CN or NO2; R3 is other than OH when m = zero.
申请公布号 IE870609(L) 申请公布日期 1987.09.11
申请号 IE19870000609 申请日期 1987.03.10
申请人 F. HOFFMANN - LA ROCHE & CO AG 发明人
分类号 C12N9/99;A61K31/12;A61K31/165;A61K31/19;A61K31/215;A61K31/275;A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/4184;A61K31/495;A61K31/496;A61P25/00;A61P25/24;A61P25/26;A61P43/00;C07C45/29;C07C45/30;C07C45/46;C07C45/67;C07C47/565;C07C47/575;C07C49/83;C07C49/84;C07C67/00;C07C69/017;C07C201/00;C07C201/12;C07C205/16;C07C205/20;C07C205/23;C07C205/37;C07C205/43;C07C205/44;C07C205/45;C07C205/56;C07C205/59;C07C239/00;C07C251/32;C07C251/34;C07C253/00;C07C255/50;C07C255/53;C07C255/54;C07C255/56;C07D209/12;C07D213/50;C07D217/16;C07D231/20;C07D231/22;C07D233/64;C07D233/88;C07D235/18;C07D241/38;C07D241/44;C07D241/52;C07D253/06;C07D253/07;C07D265/28;C07D265/36;C07D277/24;C07D277/40;C07D277/42;C07D279/16;C07D285/16;C07D295/18;C07D409/10;C07D417/00;C07D471/04;C07D513/04;C07D521/00 主分类号 C12N9/99
代理机构 代理人
主权项
地址